Tuesday, February 28, 2017

Parc East – by Trillium Development

Coming soon to Port Coquitlam is Park East by Trillium Developments. Park East will be centrally located on the corner of Atkins and Shaughnessy, a short walk to the Main Village with its all it shops and services, as well as the West Coast Express.

Park East will be consist of 57 condos consisting of one bedroom, one bedroom plus den, two bedroom, or two bedroom plus den, with size ranging from 446 square feet to 1077 square feet. Each suite at Parc East will be designed with quartz counters, stainless steel appliances, and large islands in the Kitchen, with laminate flooring throughout.

Amenities include a gym, furnished amenity room that includes a lounge area with kitchenette, and an outdoor entertaining space, as well as outdoor play area for the kids (little kids, not the big kids, thats what the lounge is for 🙂

Sales expected to start in the late winter of 2017 or early Spring with price to starting the mid 200’s. Register with us to be kept up to date with floor plans, and vip sales.

 

 

 

 

 

E. & O. E. This is not an offering for sale. An offering for sale may only be made after filing a Disclosure Statement under the Real Estate Development Marketing Act

The post Parc East – by Trillium Development appeared first on Vancouver New Condos.



from Buildings – Vancouver New Condos http://ift.tt/2mqzkMH

Parc East – by Trillium Development

Coming soon to Port Coquitlam is Park East by Trillium Developments. Park East will be centrally located on the corner of Atkins and Shaughnessy, a short walk to the Main Village with its all it shops and services, as well as the West Coast Express.

Park East will be consist of 57 condos consisting of one bedroom, one bedroom plus den, two bedroom, or two bedroom plus den, with size ranging from 446 square feet to 1077 square feet. Each suite at Parc East will be designed with quartz counters, stainless steel appliances, and large islands in the Kitchen, with laminate flooring throughout.

Amenities include a gym, furnished amenity room that includes a lounge area with kitchenette, and an outdoor entertaining space, as well as outdoor play area for the kids (little kids, not the big kids, thats what the lounge is for 🙂

Sales expected to start in the late winter of 2017 or early Spring with price to starting the mid 200's. Register with us to be kept up to date with floor plans, and vip sales.

 

 

 

 

 

E. & O. E. This is not an offering for sale. An offering for sale may only be made after filing a Disclosure Statement under the Real Estate Development Marketing Act

The post Parc East – by Trillium Development appeared first on Vancouver New Condos.



from Buildings – Vancouver New Condos http://ift.tt/2mqzkMH

The Arden

 

The Arden is coming soon to Port Coquitlam  The Arden will be a boutique building with just 22 executive size suites with Quartz countertop, stainless steel appliances and laminate flooring.  The Arden will sure be a great spot for first timers or down-sizers.

Pricing is expected to be:

1 bedroom from high $200's

1 bedroom + dens from Low $300's

2 bedroom 1 bathrooms from Mid to high $300's

2 bedroom 2 bathroom over $400,000

Completion anticipated to be Fall of 2017.  Previews start soon, register with us today to get access to this development and many others

 

 

 

E. & O. E. This is not an offering for sale. An offering for sale may only be made after filing a Disclosure Statement under the Real Estate Development Marketing Act

The post The Arden appeared first on Vancouver New Condos.



from Buildings – Vancouver New Condos http://ift.tt/2lU4XuS

The Arden

 

The Arden is coming soon to Port Coquitlam  The Arden will be a boutique building with just 22 executive size suites with Quartz countertop, stainless steel appliances and laminate flooring.  The Arden will sure be a great spot for first timers or down-sizers.

Pricing is expected to be:

1 bedroom from high $200’s

1 bedroom + dens from Low $300’s

2 bedroom 1 bathrooms from Mid to high $300’s

2 bedroom 2 bathroom over $400,000

Completion anticipated to be Fall of 2017.  Previews start soon, register with us today to get access to this development and many others

 

 

 

E. & O. E. This is not an offering for sale. An offering for sale may only be made after filing a Disclosure Statement under the Real Estate Development Marketing Act

The post The Arden appeared first on Vancouver New Condos.



from Buildings – Vancouver New Condos http://ift.tt/2lU4XuS

10 Hacks To Make Your House Smell Amazing

10 Hacks To Make Your House Smell Amazing

The other day I came home to a smelly house. I had left something extra nasty in the trash can and was totally regretting it. I immediately took it out of course but was scrambling to get the smell out!

I searched around and found some awesome smell hacks that helped me in a pinch. Keep these around for the next time you are desperate to get your home smelling great. These would be perfect if you had company coming over!

10 Hacks To Make Your House Smell Amazing

10 Hacks To Make Your House Smell Amazing

Make your whole house smell fresh with this totally chemical free hack we love.

Place a clip on air freshener for cars onto the vents in your house! via Krazy Coupon Lady

Use Gain Fireworks scent booster in your candle wax burner and your house will smell amazing. via Stock Piling Moms

Kick stinky smells in your house by filling your crock pot with water and baking soda. via A Year of Slow Cooking

Make your own room scents easily with ingredients right from your kitchen. via The Yummy Life

Place a tealight candle inside a jar filled with coffee beans for a vanilla coffee scent. via Smart School House

Banish carpet odors quickly with this simple DIY concoction.

10 Hacks To Make Your House Smell Amazing

Put a few teaspoons of vanilla extract in an oven dish and bake at 300 degrees. Your house will smell amazing. via Lifehackable

Quickly get the room smelling good by taping dryer sheets to a box fan. via Society 19

The most fun way to make your house smell great? Bake cookies! Or brownies or whatever sweet treat you have on hand.

What is your favorite smell hack?

The post 10 Hacks To Make Your House Smell Amazing appeared first on Kids Activities Blog.



from Kids Activities Blog http://ift.tt/2lQOtVY

10 Hacks To Make Your House Smell Amazing

10 Hacks To Make Your House Smell Amazing

The other day I came home to a smelly house. I had left something extra nasty in the trash can and was totally regretting it. I immediately took it out of course but was scrambling to get the smell out!

I searched around and found some awesome smell hacks that helped me in a pinch. Keep these around for the next time you are desperate to get your home smelling great. These would be perfect if you had company coming over!

10 Hacks To Make Your House Smell Amazing

10 Hacks To Make Your House Smell Amazing

Make your whole house smell fresh with this totally chemical free hack we love.

Place a clip on air freshener for cars onto the vents in your house! via Krazy Coupon Lady

Use Gain Fireworks scent booster in your candle wax burner and your house will smell amazing. via Stock Piling Moms

Kick stinky smells in your house by filling your crock pot with water and baking soda. via A Year of Slow Cooking

Make your own room scents easily with ingredients right from your kitchen. via The Yummy Life

Place a tealight candle inside a jar filled with coffee beans for a vanilla coffee scent. via Smart School House

Banish carpet odors quickly with this simple DIY concoction.

10 Hacks To Make Your House Smell Amazing

Put a few teaspoons of vanilla extract in an oven dish and bake at 300 degrees. Your house will smell amazing. via Lifehackable

Quickly get the room smelling good by taping dryer sheets to a box fan. via Society 19

The most fun way to make your house smell great? Bake cookies! Or brownies or whatever sweet treat you have on hand.

What is your favorite smell hack?

The post 10 Hacks To Make Your House Smell Amazing appeared first on Kids Activities Blog.



from Kids Activities Blog http://ift.tt/2lQOtVY

The Future Of Precision Medicine: Great Promise, Significant Challenges

Editor’s note: This post is part of a series stemming from the Fifth Annual Health Law Year in P/Review event held at Harvard Law School on Monday, January 23rd, 2017. The conference brought together leading experts to review major developments in health law over the previous year, and preview what is to come.

In his 2015 State of the Union address, President Obama launched the Precision Medicine Initiative (PMI), which is intended to help move medicine from the traditional “one-size-fits-all” approach where treatments are designed for the “average” patient, to one that “takes into account individual differences in people’s genes, environments, and lifestyles,” thereby personalizing treatment. According to the White House, a major goal is to “bring us closer to curing diseases like cancer and diabetes.” In December 2016, the 21st Century Cures Act was signed into law, authorizing up to $1.455 billion in funding for the initiative, spread over 10 years (although, importantly, the statute does not guarantee any of the funds, which will be subject to budget negotiations each year).

Central to the PMI is the All of Us Research Program (renamed in October 2016 from the “Precision Medicine Initiative Cohort Program”), which aims to enroll 1 million or more volunteers throughout the United States. If successful, it would be one of the largest longitudinal cohorts ever developed in this country. The All of Us program will, among other things, seek to ascertain the relationships between various environmental exposures, genetic factors, and other biologic determinants of disease. Volunteers will contribute data in various ways, including donating blood samples, completing baseline physical exams and online health surveys, and sharing both existing electronic health records and mobile health data. Enrollment will be possible either directly via smart phone applications developed by a Participant Technologies Center, or through participating medical centers, including community health clinics and medical centers operated by the US Department of Veterans Affairs. A Data and Research Center will acquire, organize, and provide secure access to volunteers’ health data, and the Mayo Clinic will manage a biobank of volunteers’ biological specimens to support research efforts.

The Cancer Moonshot

In January 2016, one year after the Precision Medicine Initiative was announced, President Obama in his final State of the Union address launched a related national effort, the “Cancer Moonshot.” The effort is directed by a Cancer Moonshot Task Force, chaired by the Vice President and comprising the heads of 13 federal agencies, including the Food and Drug Administration, the National Institutes of Health (NIH), and the NIH’s National Cancer Institute. The Task Force is charged with leading an effort “to double the rate of progress in the fight against cancer.” In addition to the $1.455 billion in funding allocated to the PMI, up to $1.8 billion is authorized by the 21st Century Cures Act to support cancer research over the next seven years, including research aimed at the development of cancer vaccines (this funding is also not guaranteed).

Challenges and Limitations

Despite the clear need for better treatments, commentators in a variety of forums have questioned whether the recent enthusiasm to conquer disease is more accurately viewed as “hope or hype” (e.g., The Wall Street Journal, Harvard Medical School, The New England Journal of Medicine, The Journal of the American Medical Association, The New Yorker, Leukemia Research, Baylor University Medical Center Proceedings, Science-Based Medicine, BioMed Central). While phrases such as “precision medicine” and “ending cancer as we know it” appeal to popular sentiment, they may also lead to hard-to-fulfill expectations. While scientific knowledge relevant to precision medicine has increased substantially in recent years, translating these findings into the clinic to truly transform patient care remains difficult. Considerable time and further research will be necessary to effectively utilize these findings in a clinical setting. In the case of cancer, varying genetic abnormalities within different regions of the same tumor (called “intra-tumor heterogeneity”) mean that even a breakthrough therapy that is 100 percent effective in targeting a particular genetic defect may fail to cure the entirety of the condition (see also NEJM). More broadly, the considerable genetic heterogeneity that exists within the US population will also complicate the characterization of patient groups for which new treatment approaches are efficacious.

Others have pointed out that focusing too strongly on technology and research detracts from more basic determinants of population health, such as socioeconomic or geographic disparities, environmental improvements (e.g., clean water), or other factors that have little to do with genetics but may lead to far more measurable improvements in public health. In fact, genetic factors are often not the primary cause of many chronic diseases, including cancers. As policymakers pursue new opportunities in precision medicine, they should therefore consider that the greatest gains may still be more likely to come from public health initiatives related to non-genetic factors such as diet, exercise, smoking cessation, weight loss, or other population-level preventative interventions, than from laboratory breakthroughs or precision medicine.

Where advances in precision medicine occur, the most measurable benefits may be different in kind from what some might expect. It is true that medicines targeted to a molecular defect affecting only a subgroup of people can in some cases (e.g., cystic fibrosis) provide meaningful health benefits. However, as explained by the Food and Drug Administration, medicines that are tailored to a subset of patients go hand in hand with companion diagnostics that can tell health care providers which patients are likely to benefit from particular precision medicine interventions and which are not. Because approved drugs can be offered to all patients whose conditions correspond to the approved indication (or even prescribed for off-label indications), the benefit conferred by companion diagnostics lies not with those who are determined to be likely responders (who would be offered the treatment even if no precision diagnostic were available), but with those patients deemed unlikely to respond who are spared the costs, false hopes, and potential side effects of undergoing an ineffective treatment.

Progress and Opportunities

Despite these challenges and limitations, the social and scientific context of the PMI and Cancer Moonshot are substantially different from when President Nixon declared War on Cancer in 1971. When the National Cancer Act was signed that year, the polymerase chain reaction—a fundamental tool of genetic research—was still more than a decade away. It was not until 2003 that the successful completion of the Human Genome Project provided the molecular backdrop against which scientists can unravel the genetic determinants of disease.

Since the Human Genome Project, the cost of whole genome sequencing has fallen from tens of millions of dollars to around $1,000 per genome today — even more quickly than would be predicted under Moore’s law, which in the field of computer science describes a doubling of computing power approximately every two years. CRISPR-Cas9 may perhaps have the greatest effect on precision medicine in the near future by enabling genetic defects to be edited out of the genome and resulting in the elimination of diseases with defined genetic abnormalities.

The rapid development of computer and laboratory technologies has also transformed the context of the PMI. Nearly a half century of advances according to Moore’s law means that computers have orders of magnitude more processing power than they did when Nixon was in office, providing the power to analyze the prodigious volumes of data generated from DNA sequence analysis or electronic patient health records.

Today’s global communication networks, statistical analysis software, and data sharing platforms bear little resemblance to those of the 1970s. Voluntary data contributions from patients via mobile phone applications or from wearable devices were not practical when Nixon’s War on Cancer was announced, but can now be used to help clarify relationships between diseases on the one hand, and environmental, behavioral, and genetic factors on the other. Laboratory technologies, such as next generation sequencing, have also brought us into an “omics” era, where not only genomics, but transcriptomics, epigenomics, proteomics, metabolomics, and microbiomics data can be generated in real time, enabling researchers to study for the first time the effect of multi-omics on disease pathogenesis.

The confluence of advances in genetics, research tools, and data storage and processing technology, among other things, suggests a favorable environment in which to translate these accomplishments into meaningful improvements in clinical care. For all its faults, precision medicine holds more promise now than it ever has — particularly if Congress follows through with the promised funding.

Author’s Note

Jessica Lasky-Su is a consultant to Metabolon, Inc.



from Health Affairs BlogHealth Affairs Blog http://ift.tt/2m9wb39

The Future Of Precision Medicine: Great Promise, Significant Challenges

Editor's note: This post is part of a series stemming from the Fifth Annual Health Law Year in P/Review event held at Harvard Law School on Monday, January 23rd, 2017. The conference brought together leading experts to review major developments in health law over the previous year, and preview what is to come.

In his 2015 State of the Union address, President Obama launched the Precision Medicine Initiative (PMI), which is intended to help move medicine from the traditional "one-size-fits-all" approach where treatments are designed for the "average" patient, to one that "takes into account individual differences in people's genes, environments, and lifestyles," thereby personalizing treatment. According to the White House, a major goal is to "bring us closer to curing diseases like cancer and diabetes." In December 2016, the 21st Century Cures Act was signed into law, authorizing up to $1.455 billion in funding for the initiative, spread over 10 years (although, importantly, the statute does not guarantee any of the funds, which will be subject to budget negotiations each year).

Central to the PMI is the All of Us Research Program (renamed in October 2016 from the "Precision Medicine Initiative Cohort Program"), which aims to enroll 1 million or more volunteers throughout the United States. If successful, it would be one of the largest longitudinal cohorts ever developed in this country. The All of Us program will, among other things, seek to ascertain the relationships between various environmental exposures, genetic factors, and other biologic determinants of disease. Volunteers will contribute data in various ways, including donating blood samples, completing baseline physical exams and online health surveys, and sharing both existing electronic health records and mobile health data. Enrollment will be possible either directly via smart phone applications developed by a Participant Technologies Center, or through participating medical centers, including community health clinics and medical centers operated by the US Department of Veterans Affairs. A Data and Research Center will acquire, organize, and provide secure access to volunteers' health data, and the Mayo Clinic will manage a biobank of volunteers' biological specimens to support research efforts.

The Cancer Moonshot

In January 2016, one year after the Precision Medicine Initiative was announced, President Obama in his final State of the Union address launched a related national effort, the "Cancer Moonshot." The effort is directed by a Cancer Moonshot Task Force, chaired by the Vice President and comprising the heads of 13 federal agencies, including the Food and Drug Administration, the National Institutes of Health (NIH), and the NIH's National Cancer Institute. The Task Force is charged with leading an effort "to double the rate of progress in the fight against cancer." In addition to the $1.455 billion in funding allocated to the PMI, up to $1.8 billion is authorized by the 21st Century Cures Act to support cancer research over the next seven years, including research aimed at the development of cancer vaccines (this funding is also not guaranteed).

Challenges and Limitations

Despite the clear need for better treatments, commentators in a variety of forums have questioned whether the recent enthusiasm to conquer disease is more accurately viewed as "hope or hype" (e.g., The Wall Street Journal, Harvard Medical School, The New England Journal of Medicine, The Journal of the American Medical Association, The New Yorker, Leukemia Research, Baylor University Medical Center Proceedings, Science-Based Medicine, BioMed Central). While phrases such as "precision medicine" and "ending cancer as we know it" appeal to popular sentiment, they may also lead to hard-to-fulfill expectations. While scientific knowledge relevant to precision medicine has increased substantially in recent years, translating these findings into the clinic to truly transform patient care remains difficult. Considerable time and further research will be necessary to effectively utilize these findings in a clinical setting. In the case of cancer, varying genetic abnormalities within different regions of the same tumor (called "intra-tumor heterogeneity") mean that even a breakthrough therapy that is 100 percent effective in targeting a particular genetic defect may fail to cure the entirety of the condition (see also NEJM). More broadly, the considerable genetic heterogeneity that exists within the US population will also complicate the characterization of patient groups for which new treatment approaches are efficacious.

Others have pointed out that focusing too strongly on technology and research detracts from more basic determinants of population health, such as socioeconomic or geographic disparities, environmental improvements (e.g., clean water), or other factors that have little to do with genetics but may lead to far more measurable improvements in public health. In fact, genetic factors are often not the primary cause of many chronic diseases, including cancers. As policymakers pursue new opportunities in precision medicine, they should therefore consider that the greatest gains may still be more likely to come from public health initiatives related to non-genetic factors such as diet, exercise, smoking cessation, weight loss, or other population-level preventative interventions, than from laboratory breakthroughs or precision medicine.

Where advances in precision medicine occur, the most measurable benefits may be different in kind from what some might expect. It is true that medicines targeted to a molecular defect affecting only a subgroup of people can in some cases (e.g., cystic fibrosis) provide meaningful health benefits. However, as explained by the Food and Drug Administration, medicines that are tailored to a subset of patients go hand in hand with companion diagnostics that can tell health care providers which patients are likely to benefit from particular precision medicine interventions and which are not. Because approved drugs can be offered to all patients whose conditions correspond to the approved indication (or even prescribed for off-label indications), the benefit conferred by companion diagnostics lies not with those who are determined to be likely responders (who would be offered the treatment even if no precision diagnostic were available), but with those patients deemed unlikely to respond who are spared the costs, false hopes, and potential side effects of undergoing an ineffective treatment.

Progress and Opportunities

Despite these challenges and limitations, the social and scientific context of the PMI and Cancer Moonshot are substantially different from when President Nixon declared War on Cancer in 1971. When the National Cancer Act was signed that year, the polymerase chain reaction—a fundamental tool of genetic research—was still more than a decade away. It was not until 2003 that the successful completion of the Human Genome Project provided the molecular backdrop against which scientists can unravel the genetic determinants of disease.

Since the Human Genome Project, the cost of whole genome sequencing has fallen from tens of millions of dollars to around $1,000 per genome today — even more quickly than would be predicted under Moore's law, which in the field of computer science describes a doubling of computing power approximately every two years. CRISPR-Cas9 may perhaps have the greatest effect on precision medicine in the near future by enabling genetic defects to be edited out of the genome and resulting in the elimination of diseases with defined genetic abnormalities.

The rapid development of computer and laboratory technologies has also transformed the context of the PMI. Nearly a half century of advances according to Moore's law means that computers have orders of magnitude more processing power than they did when Nixon was in office, providing the power to analyze the prodigious volumes of data generated from DNA sequence analysis or electronic patient health records.

Today's global communication networks, statistical analysis software, and data sharing platforms bear little resemblance to those of the 1970s. Voluntary data contributions from patients via mobile phone applications or from wearable devices were not practical when Nixon's War on Cancer was announced, but can now be used to help clarify relationships between diseases on the one hand, and environmental, behavioral, and genetic factors on the other. Laboratory technologies, such as next generation sequencing, have also brought us into an "omics" era, where not only genomics, but transcriptomics, epigenomics, proteomics, metabolomics, and microbiomics data can be generated in real time, enabling researchers to study for the first time the effect of multi-omics on disease pathogenesis.

The confluence of advances in genetics, research tools, and data storage and processing technology, among other things, suggests a favorable environment in which to translate these accomplishments into meaningful improvements in clinical care. For all its faults, precision medicine holds more promise now than it ever has — particularly if Congress follows through with the promised funding.

Author's Note

Jessica Lasky-Su is a consultant to Metabolon, Inc.



from Health Affairs BlogHealth Affairs Blog http://ift.tt/2m9wb39

How The Trump Administration Could Advance Federal Prevention Policy

Chronic disease prevention was an explicit priority of the Secretaries of Health and Human Services in both of the President George W. Bush and President Barack Obama administrations. While the policies and programs may have differed across administrations, there has been a recognition by both parties that promoting wellness is an important policy objective.

Prioritizing prevention can and should remain an essential part of the Trump Administration's health priorities. Addressing the high and growing costs of chronic disease is critical to ensuring a sustainable health care system, and tackling well-known risk factors that lead to conditions such as diabetes, heart disease, and hypertension must be part of any winning strategy.

The eight years of the Obama administration have yielded particularly significant prevention investments given the passage of the Affordable Care Act (ACA). Prevention related sections of the ACA included provisions focused on individuals, businesses and workplaces, communities and states, as well as national investments such as the Prevention and Public Health Fund. While it may be too early to determine the full health impacts of these investments, the Centers for Disease Control and Prevention's (CDC) final report, Winnable Battles, demonstrated significant national progress in some areas as well as moderate progress in others. For example, fewer than 15.1 percent of adults and 10.8 percent of youth smoked cigarettes in 2015, exceeding the set target of 17.0 percent and 17.6 percent, respectively. On the other hand, the proportion of children and adolescents aged 2-19 who are obese remained at approximately 17 percent, falling short of the set target of 15.4 percent, although reductions in obesity rates have previously been noted among very young children, ages 2-5.

President Trump & Prevention Policy

Repealing and replacing the ACA is taking center stage after the election of Donald Trump. Using the Restoring Americans' Healthcare Freedom Reconciliation Act of 2015, legislation put forward by the new Secretary of Health and Human Services Dr. Tom Price, as a template, it is likely that the Prevention and Public Health Fund could be repealed given its budgetary impact. If full repeal of the ACA happens, the authority for some prevention-focused rules created through the ACA, such as rules on nutrition labeling of standard menu items at chain restaurants, would also disappear.

Beyond the ACA, however, there is reason to believe that prevention can and may play a role in the Trump Administration and Republican Congress, given the core Republican philosophical objective of reducing federal entitlement spending. While Medicare premium support and Medicaid block grants may be strategies pursued by Republican leadership to reduce government spending on health care, overall health care expenditures continue to rise as evidenced by the latest national health spending data from the Centers for Medicare and Medicaid Services. Recent data on US spending on personal health care and public health demonstrate that preventable chronic conditions such as diabetes, ischemic heart disease, and hypertension account for the highest amounts of health care spending. Without reducing the prevalence of chronic diseases, it will be difficult to achieve a sustained moderation of health care costs.

To promote chronic disease prevention, any strategy will likely adhere to two fundamental Republican principles – 1) personal responsibility and 2) locally driven solutions. There are several possible ways the Trump administration could advance prevention consistent with these principles.

Personal Responsibility

Republicans traditionally support the notion that individuals are at least partially responsible for the behaviors and actions that affect their health. To support individuals in embracing healthy behaviors, government can provide the public scientifically sound information. Public health education campaigns have been shown to be an effective evidence-based strategy in a number of prevention areas, including promoting physical activity, increasing smoking cessation, and receiving cancer screenings. The Trump Administration could leverage a number of existing public and private sector prevention campaigns such as Go4Life, an exercise and physical activity campaign from the National Institute on Aging, 80% by 2018, a campaign led by the National Colorectal Cancer Roundtable to have 80 percent of at-risk Americans screened for colorectal cancer by 2018, and the CDC's Tips From Former Smokers campaign, which has been shown to increase successful quit attempts.

In addition to providing scientifically sound information to the American public, the Trump administration could further encourage personal responsibility by supporting consumer incentives that promote wellness. For example, increasing the evidence-base for worksite wellness programs and supporting employers in establishing programs are two steps that would build upon work started under the ACA.

Second, cost-sharing reductions in public and private insurance could be used to encourage healthy behaviors. In fact, several Republican governors, such as Governor Rick Snyder of Michigan and former Governor Mike Pence of Indiana, recently expanded Medicaid in their states and tied beneficiary cost-sharing reductions to healthy behavior commitments. Third, the administration should support existing Centers for Medicare and Medicaid Services (CMS) payment policies that provide Medicare beneficiary access to evidence-based diabetes prevention programs. And fourth, the Trump administration could build on value-based insurance design principles and support first dollar insurance coverage for high-value clinical preventive services. In addition to reviewing the findings of the U.S. Preventive Services Task Force, the Trump administration should utilize the recently updated rankings of clinical preventive services by the National Commission on Prevention Priorities to promote access to these services.

Locally Driven Solutions

As a second principle, the Trump administration will also likely focus on locally driven solutions versus new "top-down" federal programs. The past decade has seen significant progress and success at the local level, supported by data and metrics around what works in prevention and for which populations. Efforts such as the County Health Rankings and Roadmaps program and the 500 Cities project supported by the Robert Wood Johnson Foundation and partners are allowing localities across the country to have a better picture of the burden of risk factors and illness affecting their population. The Trump administration could support these localities by expanding prevention research efforts at the CDC, National Institutes of Health, and Substance Abuse & Mental Health Services Administration to identify evidence-based interventions for chronic disease prevention.

As a first step, the Trump administration should support existing recommendations of the independent Community Preventive Services Task Force on successful practices for preventing asthma, diabetes, mental health, and obesity and other health issues and ensure that localities receive the technical assistance needed to implement its recommendations. From a funding perspective, federal support to states and localities makes up the largest share of their prevention dollars. The Trump administration should support funding increases for federal prevention programs, particularly in light of the possible repeal of the Prevention and Public Health Fund, and it should direct this funding toward localities ready to implement the Task Force recommendations to achieve maximum impact. Requiring that localities secure private sector matching funds to be eligible for these additional resources could enhance the sustainability of these efforts in light of uncertainty around federal grant programs. We would urge the Administration to give extra consideration to areas in greatest need, in alignment with the longstanding Republican principle of "compassionate conservatism," so that disparities are not widened as an unintended policy consequence.

The Bipartisan Pursuit Of Prevention

Not all existing federal prevention policy will be maintained in a Trump administration. Certainly, regulatory approaches will be the first to be scrutinized and the new leadership would be wise to maintain gains in tobacco control, nutrition, and cancer prevention. Nevertheless, there are additional opportunities, consistent with traditional Republican principles, to support prevention efforts the administration should pursue. To begin, the administration should review the current goals and objectives of Healthy People, which has been utilized by previous administrations for nearly four decades to set 10-year national objectives for improving the health of all Americans. Ultimately, prevention is, and must continue to be, a bipartisan pursuit. The health of Americans and of our health care system demands nothing less.



from Health Affairs BlogHealth Affairs Blog http://ift.tt/2mpn4vK

How The Trump Administration Could Advance Federal Prevention Policy

Chronic disease prevention was an explicit priority of the Secretaries of Health and Human Services in both of the President George W. Bush and President Barack Obama administrations. While the policies and programs may have differed across administrations, there has been a recognition by both parties that promoting wellness is an important policy objective.

Prioritizing prevention can and should remain an essential part of the Trump Administration’s health priorities. Addressing the high and growing costs of chronic disease is critical to ensuring a sustainable health care system, and tackling well-known risk factors that lead to conditions such as diabetes, heart disease, and hypertension must be part of any winning strategy.

The eight years of the Obama administration have yielded particularly significant prevention investments given the passage of the Affordable Care Act (ACA). Prevention related sections of the ACA included provisions focused on individuals, businesses and workplaces, communities and states, as well as national investments such as the Prevention and Public Health Fund. While it may be too early to determine the full health impacts of these investments, the Centers for Disease Control and Prevention’s (CDC) final report, Winnable Battles, demonstrated significant national progress in some areas as well as moderate progress in others. For example, fewer than 15.1 percent of adults and 10.8 percent of youth smoked cigarettes in 2015, exceeding the set target of 17.0 percent and 17.6 percent, respectively. On the other hand, the proportion of children and adolescents aged 2-19 who are obese remained at approximately 17 percent, falling short of the set target of 15.4 percent, although reductions in obesity rates have previously been noted among very young children, ages 2-5.

President Trump & Prevention Policy

Repealing and replacing the ACA is taking center stage after the election of Donald Trump. Using the Restoring Americans’ Healthcare Freedom Reconciliation Act of 2015, legislation put forward by the new Secretary of Health and Human Services Dr. Tom Price, as a template, it is likely that the Prevention and Public Health Fund could be repealed given its budgetary impact. If full repeal of the ACA happens, the authority for some prevention-focused rules created through the ACA, such as rules on nutrition labeling of standard menu items at chain restaurants, would also disappear.

Beyond the ACA, however, there is reason to believe that prevention can and may play a role in the Trump Administration and Republican Congress, given the core Republican philosophical objective of reducing federal entitlement spending. While Medicare premium support and Medicaid block grants may be strategies pursued by Republican leadership to reduce government spending on health care, overall health care expenditures continue to rise as evidenced by the latest national health spending data from the Centers for Medicare and Medicaid Services. Recent data on US spending on personal health care and public health demonstrate that preventable chronic conditions such as diabetes, ischemic heart disease, and hypertension account for the highest amounts of health care spending. Without reducing the prevalence of chronic diseases, it will be difficult to achieve a sustained moderation of health care costs.

To promote chronic disease prevention, any strategy will likely adhere to two fundamental Republican principles – 1) personal responsibility and 2) locally driven solutions. There are several possible ways the Trump administration could advance prevention consistent with these principles.

Personal Responsibility

Republicans traditionally support the notion that individuals are at least partially responsible for the behaviors and actions that affect their health. To support individuals in embracing healthy behaviors, government can provide the public scientifically sound information. Public health education campaigns have been shown to be an effective evidence-based strategy in a number of prevention areas, including promoting physical activity, increasing smoking cessation, and receiving cancer screenings. The Trump Administration could leverage a number of existing public and private sector prevention campaigns such as Go4Life, an exercise and physical activity campaign from the National Institute on Aging, 80% by 2018, a campaign led by the National Colorectal Cancer Roundtable to have 80 percent of at-risk Americans screened for colorectal cancer by 2018, and the CDC’s Tips From Former Smokers campaign, which has been shown to increase successful quit attempts.

In addition to providing scientifically sound information to the American public, the Trump administration could further encourage personal responsibility by supporting consumer incentives that promote wellness. For example, increasing the evidence-base for worksite wellness programs and supporting employers in establishing programs are two steps that would build upon work started under the ACA.

Second, cost-sharing reductions in public and private insurance could be used to encourage healthy behaviors. In fact, several Republican governors, such as Governor Rick Snyder of Michigan and former Governor Mike Pence of Indiana, recently expanded Medicaid in their states and tied beneficiary cost-sharing reductions to healthy behavior commitments. Third, the administration should support existing Centers for Medicare and Medicaid Services (CMS) payment policies that provide Medicare beneficiary access to evidence-based diabetes prevention programs. And fourth, the Trump administration could build on value-based insurance design principles and support first dollar insurance coverage for high-value clinical preventive services. In addition to reviewing the findings of the U.S. Preventive Services Task Force, the Trump administration should utilize the recently updated rankings of clinical preventive services by the National Commission on Prevention Priorities to promote access to these services.

Locally Driven Solutions

As a second principle, the Trump administration will also likely focus on locally driven solutions versus new “top-down” federal programs. The past decade has seen significant progress and success at the local level, supported by data and metrics around what works in prevention and for which populations. Efforts such as the County Health Rankings and Roadmaps program and the 500 Cities project supported by the Robert Wood Johnson Foundation and partners are allowing localities across the country to have a better picture of the burden of risk factors and illness affecting their population. The Trump administration could support these localities by expanding prevention research efforts at the CDC, National Institutes of Health, and Substance Abuse & Mental Health Services Administration to identify evidence-based interventions for chronic disease prevention.

As a first step, the Trump administration should support existing recommendations of the independent Community Preventive Services Task Force on successful practices for preventing asthma, diabetes, mental health, and obesity and other health issues and ensure that localities receive the technical assistance needed to implement its recommendations. From a funding perspective, federal support to states and localities makes up the largest share of their prevention dollars. The Trump administration should support funding increases for federal prevention programs, particularly in light of the possible repeal of the Prevention and Public Health Fund, and it should direct this funding toward localities ready to implement the Task Force recommendations to achieve maximum impact. Requiring that localities secure private sector matching funds to be eligible for these additional resources could enhance the sustainability of these efforts in light of uncertainty around federal grant programs. We would urge the Administration to give extra consideration to areas in greatest need, in alignment with the longstanding Republican principle of “compassionate conservatism,” so that disparities are not widened as an unintended policy consequence.

The Bipartisan Pursuit Of Prevention

Not all existing federal prevention policy will be maintained in a Trump administration. Certainly, regulatory approaches will be the first to be scrutinized and the new leadership would be wise to maintain gains in tobacco control, nutrition, and cancer prevention. Nevertheless, there are additional opportunities, consistent with traditional Republican principles, to support prevention efforts the administration should pursue. To begin, the administration should review the current goals and objectives of Healthy People, which has been utilized by previous administrations for nearly four decades to set 10-year national objectives for improving the health of all Americans. Ultimately, prevention is, and must continue to be, a bipartisan pursuit. The health of Americans and of our health care system demands nothing less.



from Health Affairs BlogHealth Affairs Blog http://ift.tt/2mpn4vK

States Be Warned: High-Risk Pools Offer Little Help At A High Cost

Recently, House Republican Leadership announced a new "State Innovation Grants" program as part of its plan and draft legislation to replace the Affordable Care Act (ACA). These funds could be used for high-risk pools among other purposes. Historically, high-risk pools served as an alternative to guaranteed access to broad-based private insurance for people with pre-existing conditions. Theoretically, insuring such individuals in their own pool prevents their high costs from raising average premiums for others.

Putting prior experience aside, the ACA itself offers insight into this type of program and, as our report for the Century Foundation suggests, high-risk pools' flaws may be more fatal than previously thought. The ACA created a temporary Pre-existing Condition Insurance Plan (PCIP) program to cover uninsured people with pre-existing conditions until broader market reforms took effect in 2014. PCIP addressed many of the previous shortcomings of high-risk pools: it had no waiting periods, no annual or lifetime limits on coverage, market average premiums, comprehensive benefits, and $5 billion in federal funding.

Lessons from the PCIP

Yet, even after addressing design concerns, three obstacles limited PCIP's efficacy.

First, it was difficult for program managers to chart a steady course. Challenges in predicting costs led to frequent operational changes to accelerate or slow enrollment and spending in the high-risk pool. For example, in less than four years, the program dramatically shifted its eligibility rules and outreach plans from expansive to restrictive three times. Moreover, because of the lack of competition and incentives for providers to negotiate discounts, PCIP was forced to resort to regulations to lower the prices it paid for services — a tool few state high-risk pools would have at their disposal.

Second, it was almost impossible to budget for the program due to the unpredictability of costs. Our analysis examined PCIP claims costs per enrollee as well as total claims compared to both the program's original state allotments and an alternative approach, similar to one that is being considered for Medicaid funding. It found:

Wide variation in claims per enrollee across as well as within states

The last quarter of 2012's claims per enrollee ranged from a low of about $1,600 (North Carolina) to a high of $135,900 (Vermont) for this three-month period of time. Even removing the outliers, the highest claims per enrollee (Idaho: $12,800) was eight times higher than the lowest claims per enrollee (North Carolina: $1,600). This ratio is twice as big as the difference in state Health Insurance Marketplace premiums. PCIP's claims per enrollee also changed dramatically and somewhat randomly within states over time. Comparing the last quarter of 2011 to that of 2012, thirteen states experienced a 20 percent or greater decrease in claims per enrollee, while eleven states experienced a 20 percent or greater increase.

Major differences between actual spending and the original allotments

PCIP's $5 billion in federal funding was allocated to states based on their number of uninsured residents, costs, and related factors. Yet, actual claims were twice as high as New Hampshire's allotment and half as much as allotments in seventeen other states. Thirty-seven states had claims that were more than 20 percent outside their funding allotments.

Major differences between actual spending and an alternative allotment structure

The Republican outline for its ACA replacement plan would create a Medicaid per-capita cap — a funding limit set on a per-enrollee basis which allows federal funding to fluctuate with enrollment. However, even if federal funding for PCIP had been allocated through a per-capita cap approach, thirteen states would have had spending that was more than 20 percent off from their funding allotment. And different states would have had funding shortfalls. For example, Arkansas, Ohio, Kentucky, and Wisconsin would have had spending in 2013 that exceeded their per-capita cap, whereas they had extra funding under the original PCIP allotment formula. This suggests that per-capita allotments would not have solved financial predictability problems in PCIP and states would continue to lack the certainty needed to effectively manage a high-risk pool.

Last but not least, PCIP enrollment was limited despite available funding — which meant a limited impact on individual market premiums. Even with comprehensive benefits, premiums set without medical underwriting, and an aggressive outreach campaign to eligible Americans, PCIP enrollment represented, only 0.8 to 1.6 percent of the 8.2 to 17.9 million uninsured people with pre-existing conditions in 2010, and an even smaller share of states' uninsured residents. This meager enrollment would not have an appreciable effect on premiums in the individual insurance market.

From the PCIP to State Innovation Grants

The challenges associated with high-risk pool would likely be amplified now that millions of previously uninsured people with pre-existing conditions gained coverage in the individual market. If a state were to create a new high-risk pool, it would be forced to decide whether it would move such individuals out of the individual market and, if so, how. For example, would individuals who get a bad diagnosis or have costs that trip a certain threshold lose their Marketplace coverage and be shifted to a separate pool? Would they receive the same benefits, providers, and continuity of care in a high-risk pool? If the separate risk pool were only for new applicants who were previously uninsured, how would it be viable or accomplish the policy goals of the program given that its number of potentially eligible people is even smaller than that of traditional high-risk pools or PCIP? These are not minor questions for policymakers. They have major implications on the federal budget and the health care of millions of individuals across the country.

House Republicans suggest that State Innovation Grants may not necessarily be "tied to a separate risk pooling mechanism." The American Academy of Actuaries recently outlined alternative high-risk pool reimbursement programs, such as keeping enrollees in the individual market while paying for a portion of claims above a specified dollar amount or for specified conditions. We believe such approaches could help alleviate the problems of low participation in high-risk pools, difficulty in securing price discounts, limited administrative efficiencies, and workable funding allocations. Having said that, as with any proposals, the details would affect such programs' ability to efficiently and effectively cover people with pre-existing conditions.

Moreover, proposals to replace the ACA should be measured against the baseline of the ACA's successes and not the dysfunctional market that preceded reform. Against this yardstick, high-risk pools, even with the type of funding suggested for State Innovation Grants, will likely fall far short of covering as many people with pre-existing conditions as affordably as the ACA's set of policies does now. Insurance by definition is supposed to provide coverage for unexpected high-cost services, which is why protections for people with pre-existing conditions were included in the law's reforms. Evidence shows that the law's reforms are working. Access to health care along with health outcomes is improving and enrollment in the individual market is holding steady, even with recent premium adjustments. As such, while changes to expand affordability, accessibility, and quality of health care should be debated, evidence suggests Congress should keep the ACA's set of protections for people with pre-existing conditions intact.



from Health Affairs BlogHealth Affairs Blog http://ift.tt/2lPFmVl

States Be Warned: High-Risk Pools Offer Little Help At A High Cost

Recently, House Republican Leadership announced a new “State Innovation Grants” program as part of its plan and draft legislation to replace the Affordable Care Act (ACA). These funds could be used for high-risk pools among other purposes. Historically, high-risk pools served as an alternative to guaranteed access to broad-based private insurance for people with pre-existing conditions. Theoretically, insuring such individuals in their own pool prevents their high costs from raising average premiums for others.

Putting prior experience aside, the ACA itself offers insight into this type of program and, as our report for the Century Foundation suggests, high-risk pools’ flaws may be more fatal than previously thought. The ACA created a temporary Pre-existing Condition Insurance Plan (PCIP) program to cover uninsured people with pre-existing conditions until broader market reforms took effect in 2014. PCIP addressed many of the previous shortcomings of high-risk pools: it had no waiting periods, no annual or lifetime limits on coverage, market average premiums, comprehensive benefits, and $5 billion in federal funding.

Lessons from the PCIP

Yet, even after addressing design concerns, three obstacles limited PCIP’s efficacy.

First, it was difficult for program managers to chart a steady course. Challenges in predicting costs led to frequent operational changes to accelerate or slow enrollment and spending in the high-risk pool. For example, in less than four years, the program dramatically shifted its eligibility rules and outreach plans from expansive to restrictive three times. Moreover, because of the lack of competition and incentives for providers to negotiate discounts, PCIP was forced to resort to regulations to lower the prices it paid for services — a tool few state high-risk pools would have at their disposal.

Second, it was almost impossible to budget for the program due to the unpredictability of costs. Our analysis examined PCIP claims costs per enrollee as well as total claims compared to both the program’s original state allotments and an alternative approach, similar to one that is being considered for Medicaid funding. It found:

Wide variation in claims per enrollee across as well as within states

The last quarter of 2012’s claims per enrollee ranged from a low of about $1,600 (North Carolina) to a high of $135,900 (Vermont) for this three-month period of time. Even removing the outliers, the highest claims per enrollee (Idaho: $12,800) was eight times higher than the lowest claims per enrollee (North Carolina: $1,600). This ratio is twice as big as the difference in state Health Insurance Marketplace premiums. PCIP’s claims per enrollee also changed dramatically and somewhat randomly within states over time. Comparing the last quarter of 2011 to that of 2012, thirteen states experienced a 20 percent or greater decrease in claims per enrollee, while eleven states experienced a 20 percent or greater increase.

Major differences between actual spending and the original allotments

PCIP’s $5 billion in federal funding was allocated to states based on their number of uninsured residents, costs, and related factors. Yet, actual claims were twice as high as New Hampshire’s allotment and half as much as allotments in seventeen other states. Thirty-seven states had claims that were more than 20 percent outside their funding allotments.

Major differences between actual spending and an alternative allotment structure

The Republican outline for its ACA replacement plan would create a Medicaid per-capita cap — a funding limit set on a per-enrollee basis which allows federal funding to fluctuate with enrollment. However, even if federal funding for PCIP had been allocated through a per-capita cap approach, thirteen states would have had spending that was more than 20 percent off from their funding allotment. And different states would have had funding shortfalls. For example, Arkansas, Ohio, Kentucky, and Wisconsin would have had spending in 2013 that exceeded their per-capita cap, whereas they had extra funding under the original PCIP allotment formula. This suggests that per-capita allotments would not have solved financial predictability problems in PCIP and states would continue to lack the certainty needed to effectively manage a high-risk pool.

Last but not least, PCIP enrollment was limited despite available funding — which meant a limited impact on individual market premiums. Even with comprehensive benefits, premiums set without medical underwriting, and an aggressive outreach campaign to eligible Americans, PCIP enrollment represented, only 0.8 to 1.6 percent of the 8.2 to 17.9 million uninsured people with pre-existing conditions in 2010, and an even smaller share of states’ uninsured residents. This meager enrollment would not have an appreciable effect on premiums in the individual insurance market.

From the PCIP to State Innovation Grants

The challenges associated with high-risk pool would likely be amplified now that millions of previously uninsured people with pre-existing conditions gained coverage in the individual market. If a state were to create a new high-risk pool, it would be forced to decide whether it would move such individuals out of the individual market and, if so, how. For example, would individuals who get a bad diagnosis or have costs that trip a certain threshold lose their Marketplace coverage and be shifted to a separate pool? Would they receive the same benefits, providers, and continuity of care in a high-risk pool? If the separate risk pool were only for new applicants who were previously uninsured, how would it be viable or accomplish the policy goals of the program given that its number of potentially eligible people is even smaller than that of traditional high-risk pools or PCIP? These are not minor questions for policymakers. They have major implications on the federal budget and the health care of millions of individuals across the country.

House Republicans suggest that State Innovation Grants may not necessarily be “tied to a separate risk pooling mechanism.” The American Academy of Actuaries recently outlined alternative high-risk pool reimbursement programs, such as keeping enrollees in the individual market while paying for a portion of claims above a specified dollar amount or for specified conditions. We believe such approaches could help alleviate the problems of low participation in high-risk pools, difficulty in securing price discounts, limited administrative efficiencies, and workable funding allocations. Having said that, as with any proposals, the details would affect such programs’ ability to efficiently and effectively cover people with pre-existing conditions.

Moreover, proposals to replace the ACA should be measured against the baseline of the ACA’s successes and not the dysfunctional market that preceded reform. Against this yardstick, high-risk pools, even with the type of funding suggested for State Innovation Grants, will likely fall far short of covering as many people with pre-existing conditions as affordably as the ACA’s set of policies does now. Insurance by definition is supposed to provide coverage for unexpected high-cost services, which is why protections for people with pre-existing conditions were included in the law’s reforms. Evidence shows that the law’s reforms are working. Access to health care along with health outcomes is improving and enrollment in the individual market is holding steady, even with recent premium adjustments. As such, while changes to expand affordability, accessibility, and quality of health care should be debated, evidence suggests Congress should keep the ACA’s set of protections for people with pre-existing conditions intact.



from Health Affairs BlogHealth Affairs Blog http://ift.tt/2lPFmVl

Making Time for Your Kids

Making Time for Your Kids

When life is busy it can be hard to be intentional about making time for your kids. The whirlwind of to do lists, carpool, cleaning, and cooking is overwhelming to say the least.

I know I'm not the only one who has been staring at my phone, scrolling through Pinterest, and trying to figure out how to make my flower beds the best on the block this spring. Only when these little insignificant things were taking time away from my family did I realize that I needed a change.

Making Time for Your Kids

This isn't to say I don't engage in things like this anymore. Yes I still want to have a beautiful flower garden, but it is no longer a priority of mine to have the best on the block. Instead of trying to be perfect all of the time I am trying to engage more with my family.

It doesn't take much. All kids need is a few of your minutes per day of undivided attention to fill their love tank. I read the book Hands Free Mama by Rachel Macy Stafford and it inspired me to actually look at my daughter in her eyes when we are having a conversation rather than focusing on something else (like my phone!) and giving her a half hearted response.

Making Time for Your Kids

Here are 15 things you can do to make time for your kids and give them that one on one interaction that they need so badly.

  1. Go on a walk together. You would be amazed at the conversations that come up!
  2. If you have young kids, take them to the park.
  3. Have a family game night.
  4. Make it a tradition for you all to sit down every Sunday night and have movie night!
  5. Sit down and color in coloring books with them.
  6. Ask them to show you something that they are passionate about.
  7. Take them to get ice cream. It will make them feel so special.
  8. Spend one on one time with them. Without the other children if possible!
  9. Sit down with them while they do their homework and help them or have them explain to you what they are learning.
  10. Eat dinner together at the dinner table. No electronics! Have each person tell the rest of the family something good that happened that day.
  11. Let them help you cook dinner. Sometimes you can't avoid being busy, but you can still engage with your children in unique ways like this!
  12. Do a simple craft or activity with them.
  13. Give them a specific and regular time to have you all to themselves. That way they know when it is coming and can look forward to it!
  14. Read a book together.
  15. Play outside with them! Even if you end up just watching, do not play on your phone.

Putting your phone down and engaging can be a hard habit to break. So if at all possible, when you are spending this one on one time with your kids just leave it in the other room.

Life is so much less stressful for me now that I know that my kids won't care about mom being just as good as the other moms at the bake sale. What they truly care about is me making time for them and enjoying our time together.

We share so much more great parenting advice on our Facebook page!

The post Making Time for Your Kids appeared first on Kids Activities Blog.



from Kids Activities Blog http://ift.tt/2luL1h6

Making Time for Your Kids

Making Time for Your Kids

When life is busy it can be hard to be intentional about making time for your kids. The whirlwind of to do lists, carpool, cleaning, and cooking is overwhelming to say the least.

I know I’m not the only one who has been staring at my phone, scrolling through Pinterest, and trying to figure out how to make my flower beds the best on the block this spring. Only when these little insignificant things were taking time away from my family did I realize that I needed a change.

Making Time for Your Kids

This isn’t to say I don’t engage in things like this anymore. Yes I still want to have a beautiful flower garden, but it is no longer a priority of mine to have the best on the block. Instead of trying to be perfect all of the time I am trying to engage more with my family.

It doesn’t take much. All kids need is a few of your minutes per day of undivided attention to fill their love tank. I read the book Hands Free Mama by Rachel Macy Stafford and it inspired me to actually look at my daughter in her eyes when we are having a conversation rather than focusing on something else (like my phone!) and giving her a half hearted response.

Making Time for Your Kids

Here are 15 things you can do to make time for your kids and give them that one on one interaction that they need so badly.

  1. Go on a walk together. You would be amazed at the conversations that come up!
  2. If you have young kids, take them to the park.
  3. Have a family game night.
  4. Make it a tradition for you all to sit down every Sunday night and have movie night!
  5. Sit down and color in coloring books with them.
  6. Ask them to show you something that they are passionate about.
  7. Take them to get ice cream. It will make them feel so special.
  8. Spend one on one time with them. Without the other children if possible!
  9. Sit down with them while they do their homework and help them or have them explain to you what they are learning.
  10. Eat dinner together at the dinner table. No electronics! Have each person tell the rest of the family something good that happened that day.
  11. Let them help you cook dinner. Sometimes you can’t avoid being busy, but you can still engage with your children in unique ways like this!
  12. Do a simple craft or activity with them.
  13. Give them a specific and regular time to have you all to themselves. That way they know when it is coming and can look forward to it!
  14. Read a book together.
  15. Play outside with them! Even if you end up just watching, do not play on your phone.

Putting your phone down and engaging can be a hard habit to break. So if at all possible, when you are spending this one on one time with your kids just leave it in the other room.

Life is so much less stressful for me now that I know that my kids won’t care about mom being just as good as the other moms at the bake sale. What they truly care about is me making time for them and enjoying our time together.

We share so much more great parenting advice on our Facebook page!

The post Making Time for Your Kids appeared first on Kids Activities Blog.



from Kids Activities Blog http://ift.tt/2luL1h6

Monday, February 27, 2017

Brooklynn

Much like Maplewood Village and Lions Gate Village, Lynn Creek/Seylynn is undergoing a transformation into a walkable, transit oriented hub.  Brooklynn by Wanson Developments will be the next development to come up in the Lynn Creek/Seymour Village centre. Brooklynn will be a mixed use building consisting of ground floor retail and 63 1, 2 & 3 Bedroom condos.

More information and sales are expected to be released in March of 2017, register with us today to be kept up to date on this development and may others like it coming to the North Shore.

 

 

 

E. & O. E. This is not an offering for sale. An offering for sale may only be made after filing a Disclosure Statement under the Real Estate Development Marketing Act

The post Brooklynn appeared first on Vancouver New Condos.



from Buildings – Vancouver New Condos http://ift.tt/2limGu2

Brooklynn

Much like Maplewood Village and Lions Gate Village, Lynn Creek/Seylynn is undergoing a transformation into a walkable, transit oriented hub.  Brooklynn by Wanson Developments will be the next development to come up in the Lynn Creek/Seymour Village centre. Brooklynn will be a mixed use building consisting of ground floor retail and 63 1, 2 & 3 Bedroom condos.

More information and sales are expected to be released in March of 2017, register with us today to be kept up to date on this development and may others like it coming to the North Shore.

 

 

 

E. & O. E. This is not an offering for sale. An offering for sale may only be made after filing a Disclosure Statement under the Real Estate Development Marketing Act

The post Brooklynn appeared first on Vancouver New Condos.



from Buildings – Vancouver New Condos http://ift.tt/2limGu2

Cedar Reach at Maplewood

After the very successful development of Loden Green by Guildford Developments and Maplewood Place by Anthem, as well as the Northwood Estates Rental suite and shopping centre,  Maplewood Villages is rapidly becoming a hot spot in North Vancouver. Cedar Reach is the newest development coming soon to the area.  Cedar Reach will be modern collection of homes featuring 163 One, Two, and Three bedroom homes in the heart of Maplewood Village.  Within a short stroll to Northwood Shopping centre, including Strong's Market, Deep Cove Brewing. banking and liquor store, Cedar Reach will be designed with West Coast architecture and storage space for all your gear to fully enjoy the outdoors its surrounded by.

If you'd like to receive more information on this development or any other coming to the North Shore, register with us today to be kept up to date.

 

 

 

E. & O. E. This is not an offering for sale. An offering for sale may only be made after filing a Disclosure Statement under the Real Estate Development Marketing Act

The post Cedar Reach at Maplewood appeared first on Vancouver New Condos.



from Buildings – Vancouver New Condos http://ift.tt/2lZYIrg

Cedar Reach at Maplewood

After the very successful development of Loden Green by Guildford Developments and Maplewood Place by Anthem, as well as the Northwood Estates Rental suite and shopping centre,  Maplewood Villages is rapidly becoming a hot spot in North Vancouver. Cedar Reach is the newest development coming soon to the area.  Cedar Reach will be modern collection of homes featuring 163 One, Two, and Three bedroom homes in the heart of Maplewood Village.  Within a short stroll to Northwood Shopping centre, including Strong’s Market, Deep Cove Brewing. banking and liquor store, Cedar Reach will be designed with West Coast architecture and storage space for all your gear to fully enjoy the outdoors its surrounded by.

If you’d like to receive more information on this development or any other coming to the North Shore, register with us today to be kept up to date.

 

 

 

E. & O. E. This is not an offering for sale. An offering for sale may only be made after filing a Disclosure Statement under the Real Estate Development Marketing Act

The post Cedar Reach at Maplewood appeared first on Vancouver New Condos.



from Buildings – Vancouver New Condos http://ift.tt/2lZYIrg

Belle Isle by Citimark Developments

Lions Gate Village was approved under the new OCP a couple years ago, we are now seeing the changes coming with Park West slated to begin sales in the coming months, as well as Larco’s rental community, but Belle Isle will be the first ground oriented townhome development, when all phases are completed will include 164, 1, 2

, and 3 bedroom townhomes and garden flats.

Belle Isle will be centrally located in a new community within walking distance of Park Royal, a 15 minute drive to downtown and quick access to bus routes directly downtown, or anywhere on the North Shore

To be kept up to date on this development or any on the North Shore register with us today.

E. & O. E. This is not an offering for sale. An offering for sale may only be made after filing a Disclosure Statement under the Real Estate Development Marketing Act

The post Belle Isle by Citimark Developments appeared first on Vancouver New Condos.



from Buildings – Vancouver New Condos http://ift.tt/2lPLETw

Belle Isle by Citimark Developments

Lions Gate Village was approved under the new OCP a couple years ago, we are now seeing the changes coming with Park West slated to begin sales in the coming months, as well as Larco's rental community, but Belle Isle will be the first ground oriented townhome development, when all phases are completed will include 164, 1, 2

, and 3 bedroom townhomes and garden flats.

Belle Isle will be centrally located in a new community within walking distance of Park Royal, a 15 minute drive to downtown and quick access to bus routes directly downtown, or anywhere on the North Shore

To be kept up to date on this development or any on the North Shore register with us today.

 

The post Belle Isle by Citimark Developments appeared first on Vancouver New Condos.



from Buildings – Vancouver New Condos http://ift.tt/2lPLETw

From Machine-Readable Provider Directories, A Preview Of A Revolution

Amidst recent and anticipated changes in health insurance markets, there has been a growing trend towards increased transparency of provider networks. An important part of this effort is the implementation of standardized, machine-readable provider directories. By enabling the aggregation of provider information and plan comparisons as never before, these directories permit researchers and regulators to advance what we know about health plan provider networks, including to what extent providers in those networks report that they are accepting new patients. This advance in network information and transparency comes at an important time—as policymakers consider new balances between regulatory requirements, product diversity, and consumer choice.

Background: Concerns with Provider Networks and Directories

With the establishment of health insurance exchanges in 2014, health insurers faced increasing pressure to narrow their commercial plan provider networks. Studies led by health economist Daniel Polsky and Janet Weiner and the consulting firms Avalere and McKinsey documented the "narrowness" of many of these networks. There are good reasons why health insurers chose to do this, including cost savings and the desire to drive business toward the providers that most effectively serve the unexpectedly sick and higher-cost populations that enrolled in these plans. Medical Loss Ratio-required rebates for high administrative costs forced insurers to look at the costs of maintaining providers that serve few plan members. Further, the exchange shopping experience, which, to date, allows consumers to compare plan cost sharing while providing scant information in most states on quality and number of providers, further incents the narrowing of networks. Studies suggest that narrow networks are not inherently bad. For example, research conducted by Simon Haeder et al. in Health Affairs and JAMA , in 2015 found no quality differential between narrow and broader network plans in the California market.

Nonetheless, consumer advocates and some regulators remain worried by the trend toward narrow network health plans. Heading into 2014, United HealthGroup and Anthem, to name just two, whittled-out certain hospitals and physicians from their Medicare Advantage and new Health Insurance Exchange networks. Although the insurers continued to meet regulatory network adequacy standards, these moves generated critical media coverage and queries from state insurance commissioners and members of Congress. Government watch-dogs were dispatched, and by the end of 2015, the Department of Health and Human Services (DHHS) Inspector General, the California State Auditor, and the Government Accountability Office had all issued unflattering reports on Medicaid and Medicare Advantage provider networks. Their studies suggested patterns of inaccuracies with reported provider networks, long appointment times in the Medicaid program, and gaps in oversight of provider networks in the Medicare Advantage program. Recent CMS provider directory oversight activities suggest continued widespread directory inaccuracies that prompted the agency to issue 21 warning letters. As of March 2016, six lawsuits were filed by enrollees against health plans claiming that they were misled into selecting plans based on incorrect information in the plan's provider directory (one of these cases recently settled for $15 million).

A year ago, the National Association of Insurance Commissioners finalized a new model Network Adequacy Model Act. While the model does not have legal standing, it serves as a best practice for states to consider. Since that time, a handful of states — including Colorado, Georgia, Maryland, Ohio, and Connecticut — have passed laws or promulgated regulations establishing new or higher standards for health plan provider networks; a little more than half of the states were already conducting network reviews in keeping with much of the model act. Meanwhile, the Centers for Medicare & Medicaid Services (CMS) warned of additional oversight of Medicare Advantage provider networks in its 2017 Call Letter, and pushed state Medicaid agencies to do the same in 2018 via recent regulation.

Toward a Machine Readable Revolution

Most agree that consumers have a right to access accurate information regarding the physicians and facilities that are in network. Yet the error rate in provider directories is high; common problems include incorrect addresses and phone numbers and outdated listings of network providers and providers accepting new patients. Studies of selected Medicaid and Medicare Advantage network providers by the DHHS Office of the Inspector General and CMS have suggested error rates over 40 percent. Of course, many of the detected errors owe more to provider inattention than health plan negligence, and not all of these errors (i.e., incorrect fax numbers) impact the consumer experience. But the quantity of errors is, nonetheless, concerning.

While the implementation of machine readable directories has been, at times, painful and prone to glitches, it is producing some notable outcomes. First, CMS and some states use the directories as the data source for "doc finder" tools that enable a consumer to enter a physician or facility and easily find out plans in which that provider participates. Second, they permit the regulator to more effectively assess provider networks throughout the year. Third, they permit researchers to compare provider networks and launch other inquiries that were previously labor prohibitive. Regulators that become aware of directory errors and wish to monitor error rates will find it easier to check and recheck machine readable directories.

A handful of states that run their own health insurance exchanges—including New York, Washington, Maryland, and Colorado—required machine readable provider directories as early as 2014. CMS has required this data to be published in JSON (JavaScript Object Notation) format for federal exchanges since 2016, meaning that 35 additional states now have provider directories in a common machine readable format. Per last year's regulation, machine readable directories will be implemented nationally for Medicaid in 2018. Absent a reversal of policy, a machine readable revolution is now underway.

In a related development, CMS is using the machine-readable data to pilot a measure that would allow consumers shopping on Healthcare.gov to compare plans by relative network size within a given county. This measure, called the Provider Participation Rate (PPR), reflects the proportion of participating providers in a specialty in a given county that are in a plan's network. It is being piloted to categorize networks for primary care, pediatrics, or hospitals as Basic (Narrow), Standard, or Broad in four states (Texas, Ohio, Tennessee, and Maine) in 2017. Importantly, this approach stops far short of a "national provider database" that was foreshadowed in earlier CMS Medicare Advantage guidance and the agency backed away from a previous proposal to establish national network adequacy standards for Exchange plans. (A summary of the CMS network breadth pilot was published in the Health Affairs Blog last May). CMS's goal appears to be ensuring "network transparency" rather than establishing national standards. States are the primary regulators of network adequacy, even in the federally run exchanges.

We are also beginning to see the results of research facilitated by machine readable provider directories. Daniel Polsky, Zuleyha Cidav, and Ashley Swanson, recently published research in Health Affairs which demonstrates a correlation between plan premium and network breadth. NORC at the University of Chicago has created customized analytics dashboards for health plans using this provider directory data. In an issue brief published in September, NORC released findings showing that what constitutes basic (i.e., narrow) and broad networks varies greatly across and within states, as does the overall network breadth of certain insurer types. Below, we also present first-time data on physicians' new patient acceptance rates—analyses made possible by machine readable directories.

New Member Acceptance Rates

Some researchers, regulators, and advocates have raised concerns about health plans that may technically be "adequate"—in that they have enough providers to serve their existing members—but which are actually inadequate for new members who cannot find physicians willing to accept new patients. Critics have often portrayed this problem as particularly acute among patients seeking primary care physicians who are often in short supply. There has been little to no data analysis of new patient acceptance rates to show evidence of this problem, but that is beginning to change.

As part of their Provider Network IQ project, researchers at NORC gathered the machine-readable provider network JSON files made available by machine readable directories required by the Center for Consumer Information & Insurance Oversight (CCIIO) within CMS for plan year 2016. NORC then cleaned and aggregated the data files using the R statistical software package, focusing on de-duplication of providers and mapping networks to counties. In addition to specialty information included within the JSON files, NORC brought in ancillary data from the National Plan and Provider Enumeration System (NPPES) to ensure that each provider was mapped to the correct specialty. For 2016, our dataset comprises 1,172,626 unique providers and facilities participating in networks from 233 QHP issuers in the federally-facilitated marketplaces (FFMs).

Machine readable directories and the resulting data are far from perfect: health plans and researchers have noted the limitations of the current JSON specifications. This makes perfect compliance impossible, at least in year one. Beyond technical issues, the directories contain self-reported data with similar errors as the pdf and paper directories they replace.

Nevertheless, our findings represent the first data on this important topic, gathered by examining machine readable directories from exchange plans.

Acceptance Rates For New Patients By Geographic Type, 2016

  Overall Urban Midsize Rural
Adult Primary Care 93.4% 92.2% 92.5% 97.1%
Pediatrics 94.9% 93.3% 95.6% 97.6%

Acceptance Rates For New Patients By Type Of Insurer, 2016

  Overall BCBS Integrated Health Plans National For-Profit CO-OP Medicaid
Adult Primary Care 93.4% 93.3% 97.7% 95.4% 98.5% 90.1%
Pediatrics 94.9% 95.2% 98.5% 97.0% 98.7% 91.1%

BCBS: Refers to qualified health plans offered by the local BCBS affiliate plan.

Integrated Health Plans: In this study, we define an integrated health plan as a network of providers that care for a particular patient population. Our definition focuses on health systems that also offer their own health plan, as opposed to systems that are integrated but are not also functioning as payers.

Medicaid: Insurers offering qualified health plans in the exchange whose primary or original line of business was Medicaid managed care.

Nationally, 93.4 percent of adult primary care physicians participating in exchange plans in states where the federal government administers the exchange reported via the plan's directory that they are accepting new patients in 2016. That rate is only 1.5 percentage points lower than the rate of pediatricians who reported that they were accepting new patients in 2016. The acceptance rate is notably higher in rural counties, which is important because the quantity of providers in rural counties is lower. Acceptance rates for different types of insurers—Blue Cross Blue Shield plans, integrated health systems, national for-profit plans, co-ops, and Medicaid plans—is fairly consistent. However, Medicaid plans have the lowest new patient acceptance rate, which may be a result of the lower reimbursement rates commonly attributed to plans that operate primarily in the Medicaid market.

Due to the limitations noted above, all data aggregated from the machine readable directories must be viewed with some skepticism. Our analysis required numerous rounds of data cleaning due to issues such as duplicate or missing provider identifiers, which necessitated bringing in ancillary data from the NPPES.

Products of the Revolution: Improved Accuracy and Regulatory 'Harmonization'

To date, there has not been a study of the level of effort necessary to maintain machine readable directories — until this is considered, it is reasonable to wonder if the benefits of machine readable directories and other investments in increased network oversight merit the costs. At a time when the affordability of health insurance products is at the forefront of public discussion, it is important to be cognizant of anything that might further raise the costs of these products. But, as we discuss below, there are reasons to believe that the accuracy of these directories will improve over time and that there could be a corresponding reduction in costs to maintaining and using the data.

What does the future hold for provider directories? We believe, first, that we will see improved accuracy, and second, that machine readable directories will become the new normal across "harmonized" health insurance markets.

Improved Accuracy

Spurred by concerns with widespread inaccuracies, the health insurance industry and allied vendors are implementing solutions to improve the quality of provider directories. America's Health Insurance Plans, the industry's largest trade association, has implemented a pilot program featuring a single vendor providing directory checks as a shared service for subscribing plans in a given state. CAQH, a nonprofit alliance of health plans and trade associations, has implemented a program to harness provider credentialing information to improve directory accuracy. Second to None, a mystery shopping firm that supports many insurers has implemented a provider office outbound calling solution to confirm that provider offices offer the public the same information as listed in the provider directory. CAPG's Sanator Provider Directory Initiative uses an application program interface (API) to track customer complaints about network data inaccuracy and then follows up with providers to address the issues. Quest Analytics offers health insurer clients a suite of provider information validation tools. And NORC's custom analytic tool facilitates access to an unprecedented level of plan and county-level comparative information. While all of these solutions require time and investments, it is easy to see how these efforts will improve the accuracy and transparency of provider network information in the future.

The New Normal

Currently, machine readable directories will likely increase in use. They are already required in most of the exchanges. They will be required in Medicaid—the largest government managed care market—in 2018. CMS has previously spoken favorably about machine readable directories in Medicare Advantage guidance although it has not required machine directories in this program yet. In different guidance, as already noted, CMS has signaled a preference for "harmonizing" provider network requirements across Medicaid, Medicare Advantage, and the exchanges. Beyond the CMS-refereed markets, with most health insurers comfortably using machine readable files by 2018, more states may be tempted to bring it into the off-exchange commercial market, although states adapt to new technologies on their own timetables and according to unique market conditions. If policymakers seek alternatives to rigid network adequacy standards, the network transparency facilitated by machine readable directories could become attractive.

All of this suggests that in the next few years provider networks will be more easily and frequently measured, and directories will become increasingly accurate. The normalization of machine readable directories over time will also permit regulators and researchers to consider measures of network stability for the first time — by which provider network continuity can be considered alongside adequacy and accuracy. There could soon be a lens for understanding differences in health plans across insurance markets — commercial, Medicaid, and Medicare. All of this will, ultimately, revolutionize our understanding of how health plans and regulators ensure enrollees have access to providers and needed services.

Authors' Note

We thank Aaron Wesolowski and Matthew Green of NORC and Samantha Strong of FaegreBD for providing research and analytic support in developing this essay.



from Health Affairs BlogHealth Affairs Blog http://ift.tt/2mmBPQ0